# Chemoradiotherapy in Patients With Localised Lung Cancer

> **NCT00193921** · PHASE2 · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 82 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma

## Interventions

- **DRUG:** Vinorelbine
- **RADIATION:** High dose Radiotherapy
- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin
- **RADIATION:** High Dose Radiotherapy

## Key facts

- **NCT ID:** NCT00193921
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2009-12
- **Final completion:** 2012-12
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2014-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193921, "Chemoradiotherapy in Patients With Localised Lung Cancer". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00193921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*